Inventor
RAY CAMPHAUSEN
Inventor
US
Overview
Patents· 9 as inventor
Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.
A61Kprimary
A61KPreparations for medical, dental or toiletry purposes26%
C07KPeptides26%
C12NMicroorganisms or enzymes20%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations14%
C40BCombinatorial chemistry9%
G01NInvestigating or analysing materials by determining their chemical or physical properties6%
PatentTitleYear
12,534,511Serum albumin-binding fibronectin type III domains202612,247,058Nucleic acids encoding modified FGF-21 polypeptides, vectors and cells containing, and use thereof202511,858,979Fibronectin based scaffold domain proteins that bind PCSK9202411,408,093Fibronectin binding domains with reduced immunogenicity202211,279,751Fibronectin binding domains with reduced immunogenicity202211,248,031Methods of treating diseases associated with fibrosis using modified FGF-21 polypeptides202211,203,630Serum albumin-binding fibronectin type III domains202111,161,893Fibronectin based scaffold proteins having improved stability202111,149,077Targeted therapeutics based on engineered proteins for tyrosine kinases receptors, including IGF-IR2021Career & activity timeline
Assembled from patent assignee/location history and declaration credentials.
2021–2026Patents assigned to BRISTOL MYERS SQUIBB CO (9)· patent assignee history
2021–2026Based in US· patent location history
2024Patents assigned to BRISTOL MEYERS SQUIBB CO (1)· patent assignee history
Inventor activity
Assignee and location history derived from the patent record.
Assignees
| Assignee | Patents | Span |
|---|---|---|
| BRISTOL MYERS SQUIBB CO | 9 | 2021–2026 |
| BRISTOL MEYERS SQUIBB CO | 1 | 2024 |
Locations
| Location | Patents | Span |
|---|---|---|
| US | 9 | 2021–2026 |